Therapeutic advances in amyotrophic lateral sclerosis
- 1 July 1997
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 18 (4) , 196-203
- https://doi.org/10.1016/s0165-6147(97)90623-4
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Molecular genetic basis of familial ALSNeurology, 1996
- Altered expression of bcl‐2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neuronsAnnals of Neurology, 1996
- Motor Neuron Degeneration Induced by Excitotoxin Agonists Has Features in Common with those Seen in the SOD-1 Transgenic Mouse Model of Amyotrophic Lateral SclerosisJournal of Neuropathology and Experimental Neurology, 1996
- Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral SclerosisScience, 1996
- Apoptosis related antigen, LeY and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosisActa Neuropathologica, 1994
- Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase MutationScience, 1994
- ALS, SOD and peroxynitriteNature, 1993
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993
- A quantitative electrophysiological study of motor neurone disease.Journal of Neurology, Neurosurgery & Psychiatry, 1978
- Preservation of a certain motoneurone group of the sacral cord in amyotrophic lateral sclerosis: its clinical significance.Journal of Neurology, Neurosurgery & Psychiatry, 1977